The Challenge of Rheumatology Recruitment
Rheumatologic and autoimmune conditions—such as rheumatoid arthritis, psoriatic arthritis, lupus, and ankylosing spondylitis—affect millions worldwide. Yet despite decades of therapeutic advances, clinical development in these diseases continues to face major enrollment challenges.
Patients often navigate years of diagnostic uncertainty and treatment fatigue before reaching clinical research. Mobility limitations, overlapping comorbidities, and stringent inclusion criteria further narrow eligible populations.
For sponsors and CROs, these barriers mean rising costs, extended study durations, and incomplete datasets that limit scientific impact. OMNI CRS changes that equation.
Accelerating Rheumatology Enrollment with Data-Driven Precision
OMNI CRS accelerates your rheumatology enrollment with precision, compliance, and a performance-marketing engine built for complex autoimmune trials.
More than a referral vendor, OMNI CRS is a strategic partner trusted by sponsors, CROs, and research sites to deliver qualified, conversion-ready participants. Our proprietary recruitment platform combines multi-channel outreach, automated pre-screening, and real-time analytics to overcome enrollment barriers and reach under-represented populations.
Proven Impact in Autoimmune & Rheumatology Research
Working with OMNI CRS delivers measurable outcomes:
Leads generated across rheumatology and immunology studies
Proven experience in rheumatoid and psoriatic arthritis, lupus, and spondyloarthropathies
Predictable enrollment pipelines supporting CROs and sponsors with confidence
How OMNI CRS Delivers Exceptional Enrollment
Performance-Driven Outreach
Omni’s marketing engine activates patients and caregivers through geo-targeted digital ads, social engagement, provider referrals, and patient-support communities—matching individuals to nearby sites with precision.
Data-Led Targeting
Predictive analytics, lead validation, and real-time site feedback loops reduce screen-failures and optimize patient flow. Our adaptive model continuously refines targeting as campaigns progress.
Diversity-First Strategy
We prioritize inclusion—addressing linguistic, socioeconomic, and geographic barriers that limit access. OMNI CRS’s community-based outreach ensures that every campaign reflects real-world diversity.
Proprietary fraud-prevention • HIPAA / GDPR / FDA compliance • Continuous quality monitoring
Results That Move Rheumatology Research Forward
OMNI CRS has consistently reduced enrollment timelines for autoimmune and inflammatory disease studies—often 30–40% faster than industry averages—while improving retention through patient education and follow-up systems.
Our combination of data transparency, ethical outreach, and operational agility enables sponsors to forecast recruitment with confidence and sites to activate participants ready for screening.
Partner With OMNI CRS to Improve Rheumatology Trial Outcomes
Your rheumatology trial deserves a recruitment partner that brings speed, precision, and compliance to every campaign. OMNI CRS delivers reliable, scalable enrollment solutions trusted by CROs, pharma, and sites nationwide.